MedTrace Logo

Efficacy and Safety, Long-term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

NCT00212355 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 37

Last updated 2025-03-05

Study results available
· View outcomes & findings →

Summary

The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Conditions

  • Wilson's Disease

Interventions

DRUG

NPC-02

zinc acetate

Sponsors & Collaborators

  • Nobelpharma

    lead INDUSTRY

Principal Investigators

  • Koudou Ishii, M.D. · National MINAMIYOKOHAMA Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2008-04-30
Completion
2009-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00212355 on ClinicalTrials.gov